Prepublication report preview from Medtech Insight - Publishing July, 2007
This comprehensive, thoroughly researched and validated Report overviews the current healthcare systems in the European Union (EU), by country, and examines the etiology and epidemiology of the most prevalent and costly diseases and disorders in the EU.
Major diseases in the European Union (EU)––from cancer and cardiovascular disease to neurologic and psychiatric disorders––can take their toll in terms of lost days from work, hospital expenditures, and out-of-pocket costs to consumers. As the population in the EU ages and life spans increase, the incidence and prevalence of major diseases and disorders are expected to significantly impact the European healthcare industry.
This dynamic new report from Medtech Insight examines the etiology and epidemiology of the most prevalent and costly diseases and disorders in the EU including blood disorders, cancer, cardiovascular disorders, metabolic disorders, musculoskeletal disorders, neurologic and psychiatric disorders, ophthalmic disease and disorders, reproductive and genitourinary disorders, respiratory disease and disorders, and wounds, as well as selected conditions caused by infectious organisms.
In addition to the proprietary data from Medtech Insight’s internal resources that are utilized in this report, many organizations have provided data and hospital discharge information including the World Health Organization, Organization for Economic Cooperation and Development, Myasthenia Gravis Association, European Registries of Stroke Collaboration, and Alzheimer Europe.
To order reports or obtain information about special pre-publication offers from within the U.S., contact [email protected]. From outside the U.S., contact [email protected]. You can also call 1.949.219.0150 (or toll-free within the U.S. at 1.888.290.2225) or fax 1.949.219.0067.
European Disease Incidence and Prevalence
Report #A701 - July 2008
450 Pages – 95 Exhibits
PRE-PUBLICATION TABLE OF CONTENTS (7/7/08)
EXECUTIVE SUMMARY
1.EUROPEAN HEALTHCARE OVERVIEW
1.1 The European Union
1.1.1 Adoption of a Common Currency
1.1.2 The Aging Population
1.2 Selected European National Healthcare Profiles
1.2.1 France
1.2.1.1 Healthcare Organization and Reform
1.2.1.2 Hospital Services
1.2.1.3 Medical Device Reimbursement
1.2.2 Germany
1.2.2.1 Healthcare Organization and Reform
1.2.2.2 Hospital Services
1.2.2.3 Medical Device Reimbursement
1.2.3 Italy
1.2.3.1 Healthcare Organization and Reform
1.2.3.2 Hospital Services
1.2.3.3 Medical Device Reimbursements
1.2.4 Spain
1.2.4.1 Healthcare Organization and Reform
1.2.4.2 Hospital Services
1.2.4.3 Medical Device Reimbursement
1.2.5 United Kingdom
1.2.5.1 Healthcare Organization and Reform
1.2.5.2 Hospital Services
1.2.5.3 Medical Device Reimbursement
1.2.6 Benelux Countries
1.2.6.1 Healthcare Organization and Reform
1.2.6.2 Hospital Services
1.2.6.3 Medical Device Reimbursement
1.2.7 Nordic Countries
1.2.7.1 Healthcare Organization and Reform
1.2.7.2 Hospital Services
1.2.7.3 Medical Device Reimbursement
Exhibit 1-1: European Union, Population Statistics Comparison for the Years 1996, 2006, and 2016
Exhibit 1-2: France, Selected National Healthcare Statistics
Exhibit 1-3: Germany, Selected National Healthcare Statistics
Exhibit 1-4: Italy, Selected National Healthcare Statistics
Exhibit 1-5: Spain, Selected National Healthcare Statistics
Exhibit 1-6: The United Kingdom, Selected National Healthcare Statistics
Exhibit 1-7: Belgium, Selected National Healthcare Statistics
Exhibit 1-8: The Netherlands, Selected National Healthcare Statistics
Exhibit 1-9: Luxembourg, Selected National Healthcare Statistics
Exhibit 1-10: Denmark, Selected National Healthcare Statistics
Exhibit 1-11: Finland, Selected National Healthcare Statistics
Exhibit 1-12: Iceland, Selected National Healthcare Statistics
Exhibit 1-13: Norway, Selected National Healthcare Statistics
Exhibit 1-14: Sweden, Selected National Healthcare Statistics
2. BLOOD DISORDERS: ANEMIA AND HEMOPHILIA
2.1 Anemia
2.1.1 Iron-Deficiency Anemia
2.1.1.1 Etiology
2.1.1.2 Epidemiology
2.1.2 Sickle Cell Anemia
2.1.2.1 Etiology
2.1.2.2 Epidemiology
2.1.3 Febrile Illness
2.1.4 Vaso-Occlusive Crisis
2.1.5 Acute Chest Syndrome
2.1.6 Hydroxyurea
2.1.7 Future Treatments
2.1.8 Thalassemia
2.1.8.1 Etiology
2.1.8.2 Epidemiology
2.2 Hemophilia
2.2.1 Etiology
2.2.2 Epidemiology
Exhibit 2-1: Europe, Iron Deficiency Anemia, Incidence and Prevalence, by Country
Exhibit 2-2: Europe, Sickle Cell Anemia, Incidence and Prevalence, by Country
Exhibit 2-3: Europe, Thalassemia, Incidence and Prevalence, by Country
Exhibit 2-4: Europe, Hemophilia, Incidence and Prevalence, by Country
3. CANCER
3.1 Bladder Cancer
3.1.1 Etiology
3.1.2 Epidemiology
3.2 Brain Tumors
3.2.1 Etiology
3.2.2 Epidemiology
3.3 Breast Cancer
3.3.1 Etiology
3.3.2 Epidemiology
3.4 Bronchus/Lung Cancer
3.4.1 Etiology
3.4.2 Epidemiology
3.5 Cervical/Uterine Cancer
3.5.1 Etiology
3.5.2 Epidemiology
3.6 Colon/Rectal Cancer
3.6.1 Etiology
3.6.2 Epidemiology
3.7 Esophageal/Stomach Cancer
3.7.1 Etiology
3.7.2 Epidemiology
3.8 Leukemia
3.8.1 Etiology
3.8.2 Epidemiology
3.9 Liver/Pancreatic Cancer
3.9.1 Etiology
3.9.2 Epidemiology
3.10 Lymphoma
3.10.1 Etiology
3.10.2 Epidemiology
3.11 Melanoma
3.11.1 Etiology
3.11.2 Epidemiology
3.12 Oral Cancer
3.12.1 Etiology
3.12.2 Epidemiology
3.13 Ovarian Cancer
3.13.1 Etiology
3.13.2 Epidemiology
3.14 Prostate Cancer
3.14.1 Etiology
3.14.2 Epidemiology
3.15 Testicular Cancer
3.15.1 Etiology
3.15.2 Epidemiology
Exhibit 3-1: Europe, Bladder Cancer, Incidence and Prevalence, by Country
Exhibit 3-2: Europe, Brain Tumors, Incidence and Prevalence, by Country
Exhibit 3-3: Europe, Breast Cancer, Incidence and Prevalence, by Country
Exhibit 3-4: Europe, Bronchus/Lung Cancer, Incidence and Prevalence, by Country
Exhibit 3-5: Europe, Cervical/Uterine Cancer, Incidence and Prevalence, by Country
Exhibit 3-6: Europe, Colon/Rectal Cancer, Incidence and Prevalence, by Country
Exhibit 3-7: Europe, Stomach Cancer, Incidence and Prevalence, by Country
Exhibit 3-8: Europe, Leukemia, Incidence and Prevalence, by Country
Exhibit 3-9: Pancreatic Cancer, Treatment Options and Survival Rates, by Stage
Exhibit 3-10: Europe, Liver/Pancreatic Cancer, Incidence and Prevalence, by Country
Exhibit 3-11: Europe, Lymphoma, Incidence and Prevalence, by Country
Exhibit 3-12: Europe, Melanoma, Incidence and Prevalence, by Country
Exhibit 3-13: Europe, Oral Cancer, Incidence and Prevalence, by Country
Exhibit 3-14: Europe, Ovarian Cancer, Incidence and Prevalence, by Country
Exhibit 3-15: Europe, Prostate Cancer, Incidence and Prevalence, by Country
Exhibit 3-16: Europe, Testicular Cancer, Incidence and Prevalence, by Country
4. CARDIOVASCULAR DISORDERS
4.1 Cardiac Arrhythmias
4.1.1 Etiology
4.1.2 Epidemiology
4.2 Congestive Heart Failure
4.2.1 Etiology
4.2.2 Epidemiology
4.3 Heart Valve Disorders
4.3.1 Etiology
4.3.2 Epidemiology
4.4 Hypertension
4.4.1 Etiology
4.4.2 Epidemiology
4.5 Vascular Disorders
4.5.1 Aneurysm
4.5.1.1 Etiology
4.5.1.2 Epidemiology
4.5.2 Atherosclerosis/Hypercholesterolemia
4.5.2.1 Etiology
4.5.2.2 Epidemiology
4.5.3 Ischemic Heart Disease
4.5.3.1 Angina Pectoris
4.5.3.2 Etiology
4.5.3.3 Epidemiology
4.5.4 Myocardial Infarction
4.5.4.1 Etiology
4.5.4.2 Epidemiology
4.5.5 Peripheral Vascular Disease
4.5.5.1 Etiology
4.5.5.2 Epidemiology
Exhibit 4-1: Europe, Cardiac Arrhythmia, Incidence and Prevalence, by Country
Exhibit 4-2: Europe, Congestive Heart Failure, Incidence and Prevalence, by Country
Exhibit 4-3: Europe, Heart Valve Disorders, Incidence and Prevalence, by Country
Exhibit 4-4: Europe, Hypertension, Incidence and Prevalence, by Country
Exhibit 4-5: Europe, Aneurysm, Incidence and Prevalence, by Country
Exhibit 4-6: Europe, Atherosclerosis, Incidence and Prevalence, by Country
Exhibit 4-7: Europe, Ischemic Heart Disease, Incidence and Prevalence, by Country
Exhibit 4-8: Europe, Myocardial Infarction, Incidence and Prevalence, by Country
Exhibit 4-9: Europe, Peripheral Vascular Disease, Incidence and Prevalence, by Country
5. METABOLIC DISORDERS
5.1 Cholelithiasis
5.1.1 Etiology
5.1.2 Epidemiology
5.2 Chronic Kidney Disease/End-Stage Renal Disease
5.2.1 Etiology
5.2.2 Epidemiology
5.3 Diabetes Mellitus
5.3.1 Etiology
5.3.2 Epidemiology
5.4 Urolithiasis
5.4.1 Etiology
5.4.2 Epidemiology
Exhibit 5-1: Europe, Cholelithiasis, Incidence and Prevalence, by Country
Exhibit 5-2: Europe, End Stage Renal Disease, Incidence and Prevalence, by Country
Exhibit 5-3: Europe, Diabetes Mellitus, Incidence and Prevalence, by Country
Exhibit 5-4 Selected Predisposing Factors for Developing Kidney Stones
Exhibit 5-5: Europe, Urolithiasis, Incidence and Prevalence, by Country
6. MUSCULOSKELETAL DISORDERS
6.1 Arthritis
6.1.1 Etiology
6.1.2 Epidemiology
6.1.3 Rheumatoid Arthritis
6.1.3.1 Etiology
6.1.3.2 Epidemology
6.2 Carpal Tunnel Syndrome
6.2.1 Etiology
6.2.2 Epidemiology
6.3 Meniscal and Ligament/Tendon Injuries
6.3.1 Etiology
6.3.2 Epidemiology
6.4 Duchenne’s Muscular Dystrophy
6.4.1 Etiology
6.4.2 Epidemiology
6.5 Osteoporosis
6.5.1 Etiology
6.5.2 Epidemiology
Exhibit 6-1: Europe, Arthritis, Incidence and Prevalence, by Country
Exhibit 6-2: Europe, Carpel Tunnel Syndrome, Incidence and Prevalence, by Country
Exhibit 6-3: Europe, Meniscal and Ligement/Tendon Injuries, Incidence and Prevalence, by Country
Exhibit 6-4: Europe, Duchenne's Muscular Dystrophy, Incidence and Prevalence, by Country
Exhibit 6-5: Europe, Osteoporosis, Incidence and Prevalence, by Country
7. NEUROLOGIC AND PSYCHIATRIC DISORDERS
7.1 Alzheimer’s Disease
7.1.1 Etiology
7.1.2 Epidemiology
7.2 Amyotrophic Lateral Sclerosis
7.2.1 Etiology
7.2.2 Epidemiology
7.3 Cerebrovascular Disorders
7.3.1 Arteriovenous Malformation
7.3.1.1 Etiology
7.3.1.2 Epidemiology
7.3.2 Stroke
7.3.2.1 Etiology
7.3.2.3 Epidemiology
7.4 Epilepsy
7.4.1 Etiology
7.4.2 Epidemiology
7.5 Huntington’s Disease
7.5.1 Etiology
7.5.2 Epidemiology
7.6 Hydrocephalus
7.6.1 Etiology
7.6.2 Epidemiology
7.7 Multiple Sclerosis
7.7.1 Etiology
7.7.2 Epidemiology
7.8 Myasthenia Gravis
7.8.1 Etiology
7.8.2 Epidemiology
7.9 Parkinson’s Disease
7.9.1 Etiology
7.9.2 Epidemiology
7.10 Psychiatric Disorders
7.10.1 Bipolar Disorder
7.10.1.1 Etiology
7.10.1.2 Epidemiology
7.10.2 Depression
7.10.2.1 Etiology
7.10.2.2 Epidemiology
7.10.3 Schizophrenia
7.10.3.1 Etiology
7.10.3.2 Epidemiology
Exhibit 7-1: Diagnosed Alzheimer’s Disease Population
Exhibit 7-2: Europe, Alzheimer’s Disease, Incidence and Prevalence, by Country
Exhibit 7-3: Europe, Amyotrophic Lateral Scierosis, Incidence and Prevalence, by Country
Exhibit 7-4: Europe, Arteriovenous Malformation, Incidence and Prevalence, by Country
Exhibit 7-5: Europe, Stroke, Incidence and Prevalence, by Country
Exhibit 7-6: Europe, Epilepsy, Incidence and Prevalence, by Country
Exhibit 7-7: Europe, Huntington’s Disease, Incidence and Prevalence, by Country
Exhibit 7-8: Europe, Hydrocephalus, Incidence and Prevalence, by Country
Exhibit 7-9: Europe, Multiple Sclerosis, Incidence and Prevalence, by Country
Exhibit 7-10: Europe, Myasthenia Gravis, Incidence and Prevalence, by Country
Exhibit 7-11: Europe, Parkinson’s Disease, Incidence and Prevalence, by Country
Exhibit 7-12: Europe, Bipolar Disorder, Incidence and Prevalence, by Country
Exhibit 7-13: Europe, Depression, Incidence and Prevalence, by Country
Exhibit 7-14: Europe, Schizophrenia, Incidence and Prevalence, by Country
8. OPHTHALMIC DISORDERS: CATARACTS AND GLAUCOMA
8.1 Cataracts
8.1.1 Etiology
8.1.2 Epidemiology
8.2 Glaucoma
8.2.1 Etiology
8.2.2 Epidemiology
Exhibit 8-1: Europe, Cataracts, Incidence and Prevalence, by Country
Exhibit 8-2: Europe, Glaucoma, Incidence and Prevalence, by Country
9. REPRODUCTIVE AND GENITOURINARY DISORDERS
9.1 Urinary Incontinence
9.1.1 Etiology
9.1.2 Epidemiology
9.2 Female Disorders
9.2.1 Endometriosis
9.2.1.1 Etiology
9.2.1.1 Epidemiology
9.2.2 Infertility
9.2.2.1 Etiology
9.2.2.2 Epidemiology
9.3 Male Disorders
9.3.1 Benign Prostatic Hyperplasia
9.3.1.1 Etiology
9.3.1.2 Epidemiology
9.3.2 Erectile Dysfunction
9.3.2.1 Etiology
9.3.2.2 Epidemiology
9.3.3 Infertility
9.3.3.1 Etiology
9.3.3.2 Epidemiology
Exhibit 9-1: Europe, Urinary Incontinence, Incidence and Prevalence, by Country
Exhibit 9-2: Europe, Endometriosis, Incidence and Prevalence, by Country
Exhibit 9-3: Europe, Infertility, Incidence and Prevalence, by Country
Exhibit 9-4: Europe, Benign Prostatic Hyperplasia, Incidence and Prevalence, by Country
Exhibit 9-5: Europe, Erectile Dysfunction, Incidence and Prevalence, by Country
Exhibit 9-6: Europe, Infertility, Incidence and Prevalence, by Country
10. RESPIRATORY DISORDERS
10.1 Adult Respiratory Distress Syndrome
10.1.1 Etiology
10.1.2 Epidemiology
10.2 Apnea
10.2.1 Etiology
10.2.2 Epidemiology
10.3 Asthma
10.3.1 Etiology
10.3.2 Epidemiology
10.4 Cystic Fibrosis
10.4.1 Etiology
10.4.2 Epidemiology
10.5 Emphysema
10.5.1 Etiology
10.5.2 Epidemiology
10.6 Pneumothorax
10.6.1 Etiology
10.6.2 Epidemiology
10.7 Respiratory Failure
10.7.1 Etiology
10.7.2 Epidemiology
10.8 Restrictive Pulmonary Disease
10.8.1 Etiology
10.8.2 Epidemiology
Exhibit 10-1: Europe, Adult Respiratory Distress Syndrome, Incidence and Prevalence, by Country
Exhibit 10-2: Europe, Apnea, Incidence and Prevalence, by Country
Exhibit 10-3: Europe, Asthma, Incidence and Prevalence, by Country
Exhibit 10-4: Europe, Cystic Fibrosis, Incidence and Prevalence, by Country
Exhibit 10-5: Europe, Emphysema, Incidence and Prevalence, by Country
Exhibit 10-6: Europe, Pneumothorax, Incidence and Prevalence, by Country
Exhibit 10-7: Europe, Respiratory Failure, Incidence and Prevalence, by Country
Exhibit 10-8: Europe, Restrictive Pulmonary Disease, Incidence and Prevalence, by Country
11. WOUNDS
11.1 Diabetic Ulcers
11.1.1 Etiology
11.1.2 Epidemiology
11.2 Pressure Ulcers
11.2.1 Etiology
11.2.2 Epidemiology
11.3 Surgical Wounds
11.3.1 Etiology
11.3.2 Epidemiology
11.4 Traumatic Wounds
11.4.1 Etiology
11.4.1.1 Amputations
11.4.1.2 Burns
11.4.1.3 Lacerations, Contusions, and Abrasions
11.4.2 Epidemiology
Exhibit 11-1: Europe, Diabetic Ulcers, Incidence and Prevalence, by Country
Exhibit 11-2: Europe, Pressure Ulcers, Incidence and Prevalence, by Country
Exhibit 11-3: Europe, Surgical Wounds, Incidence and Prevalence, by Country
Exhibit 11-4: Classification of Burns, by Mechanism of Injury
Exhibit 11-5: Europe, Traumatic Wounds, Incidence and Prevalence, by Country
12. SELECTED CONITIONS CAUSED BY INFECTIOUS ORGANISMS
12.1 Bronchitis
12.1.1 Etiology
12.1.2 Epidemiology
12.2 Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome
12.2.1 Etiology
12.2.2 Epidemiology
12.3 Pneumonia
12.3.2 Etiology
12.3.1 Epidemiology
12.4 Transmissible Spongiform Encephalopathy
12.4.1 Etiology
12.4.1 Epidemiology
12.5 Tuberculosis
12.5.1 Etiology
12.5.2 Epidemiology
Exhibit 12-1: Europe, Bronchitis, Incidence and Prevalence, by Country
Exhibit 12-2: 2006, Acquired Immune Deficiency Syndrome, Indicator Diseases
Exhibit 12-3: 2006, European Union, Human Immunodeficiency Virus Infections, Newly Diagnosed and Rates per Million Inhabitants
Exhibit 12-4: 2006, Characteristics of New Human Immunodeficiency Virus Diagnoses, by Region
Exhibit 12-5: Europe, Human Immunodeficiency Virus, Incidence and Prevalence, by Country
Exhibit 12-6: Europe, Pneumonia, Incidence and Prevalence, by Country
Exhibit 12-7: Europe, Transmissible Spongiform Encephalopathy, Incidence and Prevalence, by Country
